Literature DB >> 33998903

The Impact of Cannabidiol on the Induction of Isoflurane Anesthesia and Recovery in Wistar Rats.

Matjaž Uršič1, Alenka Babič1, Tilen Vake1, Tomaž Snoj1.   

Abstract

Background: Beside others, neuroinhibitory and sedative effects of CBD were documented. Aim and
Methods: The aim of the study was to assess the dose-related effects of CBD premedication on the course of isoflurane anesthesia. Wistar rats were pretreated with different doses of CBD 1 h before isoflurane anesthesia. In the pretreatment, animals were given CBD at doses of 100, 20, 10, or 2 mg kg-1. Before the fifth (control) anesthesia, the animals were given only mid-chain triglyceride oil, which served as a solvent in the CBD formulation. The induction time was determined, and on awakening, the time to appearance of the flexion reflex and the recovery from anesthesia were determined.
Results: Statistical analysis showed a significantly shorter induction time if animals were pretreated with 20 mg kg-1 CBD. In addition, pretreatment with 100 mg kg-1 CBD resulted in a prolonged induction time, while on awakening, delayed appearance of reflexes and prolonged recovery from anesthesia compared to pretreatment with 20 mg kg-1 CBD were observed. Conclusions: The results indicate that the influence of CBD on the course of isoflurane anesthesia depends on the dose and can reduce the induction time. Although this study was performed in laboratory rats, in clinical practice, these data should be considered when CBD-treated patients undergo isoflurane anesthesia.

Entities:  

Keywords:  anesthesia; cannabidiol; induction; isoflurane; recovery

Mesh:

Substances:

Year:  2021        PMID: 33998903      PMCID: PMC9225406          DOI: 10.1089/can.2021.0014

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN: 2378-8763


  18 in total

Review 1.  A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.

Authors:  C Michael White
Journal:  J Clin Pharmacol       Date:  2019-02-07       Impact factor: 3.126

Review 2.  Anandamide as an intracellular messenger regulating ion channel activity.

Authors:  Mario van der Stelt; Vincenzo Di Marzo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2005-09       Impact factor: 3.072

3.  Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.

Authors:  E M Rock; D Bolognini; C L Limebeer; M G Cascio; S Anavi-Goffer; P J Fletcher; R Mechoulam; R G Pertwee; L A Parker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Cannabinoids in medicine: A review of their therapeutic potential.

Authors:  Mohamed Ben Amar
Journal:  J Ethnopharmacol       Date:  2006-03-15       Impact factor: 4.360

5.  CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.

Authors:  Alan H Tseng; Rebecca M Craft
Journal:  Psychopharmacology (Berl)       Date:  2003-09-30       Impact factor: 4.530

Review 6.  Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.

Authors:  Antonio Waldo Zuardi
Journal:  Braz J Psychiatry       Date:  2008-09       Impact factor: 2.697

Review 7.  Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects.

Authors:  Christopher S Pauli; Matthieu Conroy; Brian D Vanden Heuvel; Sang-Hyuck Park
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

Review 8.  An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies.

Authors:  Kerstin Iffland; Franjo Grotenhermen
Journal:  Cannabis Cannabinoid Res       Date:  2017-06-01

9.  Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.

Authors:  Lauri-Jo Gamble; Jordyn M Boesch; Christopher W Frye; Wayne S Schwark; Sabine Mann; Lisa Wolfe; Holly Brown; Erin S Berthelsen; Joseph J Wakshlag
Journal:  Front Vet Sci       Date:  2018-07-23

10.  US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions.

Authors:  Lori Kogan; Regina Schoenfeld-Tacher; Peter Hellyer; Mark Rishniw
Journal:  Front Vet Sci       Date:  2019-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.